Literature DB >> 4425849

Editorial: Dopa decarboxylase inhibitors.

.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4425849      PMCID: PMC1612227          DOI: 10.1136/bmj.4.5939.250

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


× No keyword cloud information.
  8 in total

1.  A method for the determination of some amino acid decarboxylases.

Authors:  V E DAVIS; J AWAPARA
Journal:  J Biol Chem       Date:  1960-01       Impact factor: 5.157

2.  A year's comparison of treatment of patients with parkinson's disease with levodopa combined with carbidopa versus treatment with levodopa alone.

Authors:  C D Marsden; J D Parkes; J E Rees
Journal:  Lancet       Date:  1973-12-29       Impact factor: 79.321

3.  Modification of Parkinsonism--chronic treatment with L-dopa.

Authors:  G C Cotzias; P S Papavasiliou; R Gellene
Journal:  N Engl J Med       Date:  1969-02-13       Impact factor: 91.245

4.  Levodopa, carbidopa, and pyridoxine in Parkinson disease. Metabolic interactions.

Authors:  H Mars
Journal:  Arch Neurol       Date:  1974-06

5.  Methyldopahydrazine as an adjunct to L-dopa therapy in parkinsonism.

Authors:  T N Chase; A M Watanabe
Journal:  Neurology       Date:  1972-04       Impact factor: 9.910

6.  Pyridoxine reversal of L-dopa effects in Parkinsonism.

Authors:  R C Duvoisin; M D Yahr; L D Coté
Journal:  Trans Am Neurol Assoc       Date:  1969

7.  Metabolism and absorption of L-3,4 dihydroxyphenylalanine in patients with Parkinson's disease.

Authors:  J R Bianchine; L R Calimlim; J P Morgan; C A Dujuvne; L Lasagna
Journal:  Ann N Y Acad Sci       Date:  1971-07-06       Impact factor: 5.691

8.  Dopa decarboxylase: substrates, coenzyme, inhibitors.

Authors:  T L Sourkes
Journal:  Pharmacol Rev       Date:  1966-03       Impact factor: 25.468

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.